RT Journal Article
SR Electronic
T1 Pan-UK Biobank GWAS improves discovery, analysis of genetic architecture, and resolution into ancestry-enriched effects
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.13.24303864
DO 10.1101/2024.03.13.24303864
A1 Karczewski, Konrad J.
A1 Gupta, Rahul
A1 Kanai, Masahiro
A1 Lu, Wenhan
A1 Tsuo, Kristin
A1 Wang, Ying
A1 Walters, Raymond K.
A1 Turley, Patrick
A1 Callier, Shawneequa
A1 Shah, Nirav N.
A1 Baya, Nikolas
A1 Palmer, Duncan S.
A1 Goldstein, Jacqueline I.
A1 Sarma, Gopal
A1 Solomonson, Matthew
A1 Cheng, Nathan
A1 Bryant, Sam
A1 Churchhouse, Claire
A1 Cusick, Caroline M.
A1 Poterba, Timothy
A1 Compitello, John
A1 King, Daniel
A1 Zhou, Wei
A1 Seed, Cotton
A1 Finucane, Hilary K.
A1 Daly, Mark J.
A1 Neale, Benjamin M.
A1 Atkinson, Elizabeth G.
A1 Martin, Alicia R.
YR 2024
UL http://medrxiv.org/content/early/2024/10/01/2024.03.13.24303864.abstract
AB Large biobanks, such as the UK Biobank (UKB), enable massive phenome by genome-wide association studies that elucidate genetic etiology of complex traits. However, individuals from diverse genetic ancestry groups are often excluded from association analyses due to concerns about population structure introducing false positive associations. Here, we generate mixed model associations and meta-analyses across genetic ancestry groups, inclusive of a larger fraction of the UKB than previous efforts, to produce freely-available summary statistics for 7,266 traits. We build a quality control and analysis framework informed by genetic architecture. Overall, we identify 14,676 significant loci (p < 5 x 10-8) in the meta-analysis that were not found in the EUR genetic ancestry group alone, including novel associations for example between CAMK2D and triglycerides. We also highlight associations from ancestry-enriched variation, including a known pleiotropic missense variant in G6PD associated with several biomarker traits. We release these results publicly alongside FAQs that describe caveats for interpretation of results, enhancing available resources for interpretation of risk variants across diverse populations.Competing Interest StatementK.J.K. is a consultant for Tome Biosciences, AlloDx, and Vor Biosciences, and a member of the scientific advisory board of Nurture Genomics. M.J.D is a founder of Maze Therapeutics. B.M.N. is a member of the scientific advisory board at Deep Genomics and Neumora.Funding StatementThis work was supported by the Novo Nordisk Foundation (NNF21SA0072102), NIH grants R37MH107649, R00MH117229, K01MH121659, F31HL167378, and F30AG074507, and BroadIgnite funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study used data from the UK Biobank. UK Biobank has approval from the North West Multi-centre Research Ethics Committee (MREC) as a Research Tissue Bank (RTB) approval. This approval means that researchers do not require separate ethical clearance and can operate under the RTB approval.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data are available at https://pan.ukbb.broadinstitute.org/, and sample metadata is available in the UK Biobank showcase under return number 2442: https://biobank.ndph.ox.ac.uk/ukb/dset.cgi?id=2442.